Comera Life Sciences Holdings, Inc. (CMRAW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
12 Gill Street
Woburn, MA 01801
United States of America (the)
Phone
617 871 2101
Sector
Healthcare
Industry
Biotechnology
Employees
12
First IPO Date
December 21, 2020
| Name | Title | Pay | Year Born |
| Michael G. Campbell | Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer | 269,109 | 1969 |
| David Soane | Co-Founder & Member of Scientific Advisory Board | 0 | N/A |
| Janice Marie McCourt | Chief Business Officer | 0 | 1962 |
Comera Life Sciences Holdings, Inc. is an early-stage life sciences company dedicated to developing its own innovative therapeutics. These treatments leverage its unique SQore formulation platform, which is engineered to convert biologics typically administered intravenously (IV) into convenient subcutaneous (SQ) versions. The company's pipeline currently features two primary drug candidates: CLS-001, an improved biologic in preclinical development, targets Crohn's and Ulcerative Colitis; and CLS-002, also in preclinical stages, is an enhanced biologic aimed at various oncological indications. Established in 2014, Comera Life Sciences is based in Woburn, Massachusetts.